605077 Zhejiang Huakang Pharmaceutical
- 13.47
- 0.000.00%
Zhejiang Huakang Pharmaceutical News
Announcement of Huakang Co., Ltd. on the progress of asset restrictions of Zhejiang Huahe Thermal Power Co., Ltd. in the Ningbo Branch of Ping An Bank Co., Ltd.
Huakang Co., Ltd.\'s indicative announcement on the update of application documents such as responses to audit inquiries on issuing convertible corporate bonds to unspecified targets
Response report to the inquiry letter on the audit of application documents for the issuance of convertible corporate bonds by Zhejiang Huakang Pharmaceutical Co., Ltd. to unspecified targets
Huakang Co., Ltd.\'s indicative announcement on the update of application documents such as responses to audit inquiries on issuing convertible corporate bonds to unspecified targets
Response report to the inquiry letter on the audit of application documents for the issuance of convertible corporate bonds by Zhejiang Huakang Pharmaceutical Co., Ltd. to unspecified targets
Huakang Co., Ltd.: Announcement by Huakang Co., Ltd. on the dilution of spot returns and compensation measures for the public issuance of convertible corporate bonds and related entities' commitments
Huakang Co., Ltd.: Feasibility analysis report on the use of funds raised by Huakang Co., Ltd. publicly issued convertible corporate bonds
Huakang Co., Ltd.: Huakang Co., Ltd.\'s 2021 Annual Equity Distribution Implementation Notice
Huakang Co., Ltd.'s 2021 Annual Equity Distribution Implementation Notice
Huakang Co., Ltd.: Huakang Co., Ltd.'s announcement on the company's 2021 profit distribution and provident fund transfer plan
Huakang Co., Ltd.: Huakang Co., Ltd.'s progress announcement on the acquisition of 100% of Gaomi Tongli Sugar Co., Ltd.
Huakang Co., Ltd.: Huakang Co., Ltd.'s announcement on the acquisition of 100% of Gaomi Tongli Sugar Co., Ltd.
Huakang Co., Ltd.: Announcement by Zhejiang Huakang Pharmaceutical Co., Ltd. on the transfer of 100% of the shares of Tangshan Huayue Food Technology Co., Ltd., a wholly-owned subsidiary
Analysis
Price Target
No Data
